Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α

Neuropharmacology

Volumn 63, Issue 2, 2012, Pages 242-249

  Zhou, Yu ^a   Yang, Lichao ^a   Ma, Ang ^a   Zhang, Xuemei ^a   Li, Weijie ^a   Yang, Wushuang ^b   Chen, Caixia ^a   Jin, Xin ^a  

^a XIAMEN UNIVERSITY   (China)

^b Xiamen Traditional Chinese Medicine Hospital   (China)

Author keywords

Blood brain barrier; Brain ischemia; Mice; Oleoylethanolamide; PPAR

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; MESSENGER RNA; N OLEOYLETHANOLAMINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; FOCAL CEREBRAL ISCHEMIA; LOW DRUG DOSE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MONOTHERAPY; MORTALITY; MOUSE; NEUROLOGICAL DEFICIT SCORE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SCORING SYSTEM; SINGLE DRUG DOSE; TREATMENT RESPONSE; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN EDEMA; BRAIN ISCHEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; MALE; MICE; OLEIC ACIDS; PPAR ALPHA; REPERFUSION INJURY;

EID: 84861977370     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.03.008     Document Type: Article

References (46)

1. Arai, K., Jin, G., Navaratna, D., Lo, E.H., 2009. Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. FEBS J. 276, 4644-4652.
2. Bederson, J.B., Pitts, L.H., Tsuji, M., Nishimura, M.C., Davis, R.L., Bartkowski, H., 1986. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17, 47-476.
3. Berger, J.P., Akiyama, T.E., Meinke, P.T., 2005. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol. Sci. 26, 24-251.
4. Bordet, R., Ouk, T., Petrault, O., Gele, P., Gautier, S., Laprais, M., Deplanque, D., Duriez, P., Staels, B., Fruchart, J.C., Bastide, M., 2006. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem. Soc. Trans. 34, 134-1346.
5. Cheng, G., Zhang, X., Gao, D., Jiang, X., Dong, W., 2009. Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model. Neurosci. Lett. 451, 10-108.
6. Chu, Z.L., Carroll, C., Chen, R., Alfonso, J., Gutierrez, V., He, H., Lucman, A., Xing, C., Sebring, K., Zhou, J., Wagner, B., Unett, D., Jones, R.M., Behan, D.P., Leonard, J., 2010. N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119. Mol. Endocrinol. 24, 16-170.
7. Collino, M., Aragno, M., Mastrocola, R., Benetti, E., Gallicchio, M., Dianzani, C., Danni, O., Thiemermann, C., Fantozzi, R., 2006. Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643. Free Radic. Biol. Med. 41, 57-589.
8. Degn, M., Lambertsen, K.L., Petersen, G., Meldgaard, M., Artmann, A., Clausen, B.H., Hansen, S.H., Finsen, B., Hansen, H.S., Lund, T.M., 2007. Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice. J. Neurochem. 103, 190-1916.
9. del Zoppo, G.J., 2006. Stroke and neurovascular protection. N. Engl. J. Med. 354, 55-555.
10. Deplanque, D., Gele, P., Petrault, O., Six, I., Furman, C., Bouly, M., Nion, S., Dupuis, B., Leys, D., Fruchart, J.C., Cecchelli, R., Staels, B., Duriez, P., Bordet, R., 2003. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J. Neurosci. 23, 626-6271.
11. Engel, O., Kolodziej, S., Dirnagl, U., Prinz, V., 2011. Modeling stroke in mice - middle cerebral artery occlusion with the filament model. J. Vis. Exp.
12. Feng, D., Zhang, Y., Chen, G., 2008. Cortical expression of peroxisome proliferator-activated receptor-alpha afterhuman brain contusion. J. Int.Med.Res. 36, 78-791.
13. Fu, J., Gaetani, S., Oveisi, F., Lo Verme, J., Serrano, A., Rodriguez De Fonseca, F., Rosengarth, A., Luecke, H., Di Giacomo, B., Tarzia, G., Piomelli, D., 2003. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425, 9-93.
14. Fu, J., Oveisi, F., Gaetani, S., Lin, E., Piomelli, D., 2005. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology 48, 114-1153.
15. Fu, J., Kim, J., Oveisi, F., Astarita, G., Piomelli, D., 2008. Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R4-R50.
16. Green,A.R., 2008. Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly. Br. J. Pharmacol. 153 (Suppl. 1), S32-S338.
17. Kehrer, J.P., Biswal, S.S., La, E., Thuillier, P., Datta, K., Fischer, S.M., Vanden Heuvel, J.P., 2001. Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886. Biochem. J. 356, 89-906.
18. Khatibi, N.H., Jadhav, V., Charles, S., Chiu, J., Buchholz, J., Tang, J., Zhang, J.H., 2011. Capsaicin pre-treatment provides neurovascular protection against neonatal hypoxic-ischemic brain injury in rats. Acta Neurochir. Suppl. 111, 22-230.
19. Lemberger, T., Braissant, O., Juge-Aubry, C., Keller, H., Saladin, R., Staels, B., Auwerx, J., Burger, A.G., Meier, C.A., Wahli, W., 1996. PPAR tissue distribution and interactions with other hormone-signaling pathways. Ann. N.Y. Acad. Sci. 804, 23-251.
20. Li, P., Murphy, T.H., 2008. Two-photon imaging during prolonged middle cerebral artery occlusion in mice reveals recovery of dendritic structure after reperfusion. J. Neurosci. 28, 1197-11979.
21. Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 40-408.
22. Lok, J., Gupta, P., Guo, S., Kim, W.J., Whalen, M.J., van Leyen, K., Lo, E.H., 2007. Cell-cell signaling in the neurovascular unit. Neurochem. Res. 32, 203-2045.
23. Massip-Salcedo, M., Zaouali, M.A., Padrissa-Altes, S., Casillas-Ramirez, A., Rodes, J., Rosello-Catafau, J., Peralta, C., 2008. Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion. Hepatology 47, 46-472.
24. Mazzola, C., Medalie, J., Scherma, M., Panlilio, L.V., Solinas, M., Tanda, G., Drago, F., Cadet, J.L., Goldberg, S.R., Yasar, S., 2009. Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. Learn Mem. 16, 33-337.
25. Moreno, S., Farioli-Vecchioli, S., Ceru, M.P., 2004. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123, 13-145.
26. Mysiorek, C., Culot, M., Dehouck, L., Derudas, B., Staels, B., Bordet, R., Cecchelli, R., Fenart, L., Berezowski, V., 2009. Peroxisome-proliferator- activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier. Curr. Neurovasc. Res. 6, 18-193.
27. O'Donnell, M., Yusuf, S., 2009. Tackling the global burden of stroke: the need for large-scale international studies. Lancet Neurol. 8, 30-307.
28. Ouk, T., Laprais, M., Bastide, M., Mostafa, K., Gautier, S., Bordet, R., 2009. Withdrawal of fenofibrate treatment partially abrogates preventive neuroprotection in stroke via loss of vascular protection. Vascul. Pharmacol. 51, 32-330.
29. Oveisi, F., Gaetani, S., Eng, K.T., Piomelli, D., 2004. Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration. Pharmacol. Res. 49, 46-466.
30. Overton, H.A., Babbs, A.J., Doel, S.M., Fyfe, M.C., Gardner, L.S., Griffin, G., Jackson, H.C., Procter, M.J., Rasamison, C.M., Tang-Christensen, M., Widdowson, P.S., Williams, G.M., Reynet, C., 2006. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 3, 16-175.
31. Pegorini, S., Zani, A., Braida, D., Guerini-Rocco, C., Sala, M., 2006. Vanilloid VR1 receptor is involved in rimonabant-induced neuroprotection. Br. J. Pharmacol. 147, 55-559.
32. Pialat, J.B., Cho, T.H., Beuf, O., Joye, E., Moucharrafie, S., Langlois, J.B., Nemoz, C., Janier, M., Berthezene, Y., Nighoghossian, N., Desvergne, B., Wiart, M., 2007. MRI monitoring of focal cerebral ischemia in peroxisome proliferator-activated receptor (PPAR)-deficient mice. NMR Biomed. 20, 33-342.
33. Plaza-Zabala, A., Berrendero, F., Suarez, J., Bermudez-Silva, F.J., Fernandez-Espejo, E., Serrano, A., Pavon, F.J., Parsons, L.H., De Fonseca, F.R., Maldonado, R., Robledo, P., 2010. Effects of the endogenous PPAR-alpha agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice. Synapse 64, 37-389.
34. Qu, Y.Z., Li, M., Zhao, Y.L., Zhao, Z.W., Wei, X.Y., Liu, J.P., Gao, L., Gao, G.D., 2009. Astragaloside IV attenuates cerebral ischemia-reperfusion- induced increase in permeability of the blood-brain barrier in rats. Eur. J. Pharmacol. 606, 13-141.
35. Sandoval, K.E., Witt, K.A., 2008. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol. Dis. 32, 20-219.
36. Schabitz, W.R., Giuffrida, A., Berger, C., Aschoff, A., Schwaninger, M., Schwab, S., Piomelli, D., 2002. Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. Stroke 33, 211-2114.
37. Strbian, D., Durukan, A., Pitkonen, M., Marinkovic, I., Tatlisumak, E., Pedrono, E., Abo-Ramadan, U., Tatlisumak, T., 2008. The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 153, 17-181.
38. Sun, Y., Alexander, S.P., Garle, M.J., Gibson, C.L., Hewitt, K., Murphy, S.P., Kendall, D.A., Bennett, A.J., 2007. Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. Br. J. Pharmacol. 152, 73-743.
39. Thabuis, C., Tissot-Favre, D., Bezelgues, J.B., Martin, J.C., Cruz-Hernandez, C., Dionisi, F., Destaillats, F., 2008. Biological functions and metabolism of oleoylethanolamide. Lipids 43, 88-894.
40. Vakili, A., Mojarrad, S., Akhavan, M.M., Rashidy-Pour, A., 2011. Pentoxifylline attenuates TNF-alpha protein levels and brain edema following temporary focal cerebral ischemia in rats. Brain Res. 1377, 11-125.
41. Walter, L., Franklin, A., Witting, A., Moller, T., Stella, N., 2002. Astrocytes in culture produce anandamide and other acylethanolamides. J. Biol. Chem. 277, 2086-20876.
42. Wang, X., Miyares, R.L., Ahern, G.P., 2005. Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1. J. Physiol. 564, 54-547.
43. Yakubu, M.A., Nsaif, R.H., Oyekan, A.O., 2010. Regulation of cerebrovascular endothelial peroxisome proliferator activator receptor alpha expression and nitric oxide production by clofibrate. Bratisl. Lek. Listy 111, 25-264.
44. Ye, Y.L., Shi, W.Z., Zhang, W.P., Wang, M.L., Zhou, Y., Fang, S.H., Liu, L.Y., Zhang, Q., Yu, Y.P., Wei, E.Q., 2007. Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic brain injuries. Eur. J. Pharmacol. 557, 2-31.
45. Yenari, M.A., Xu, L., Tang, X.N., Qiao, Y., Giffard, R.G., 2006. Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 37, 108-1093.
46. Zlokovic, B.V., 2008. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 17-201.